Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mallari

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The British Journal of Dermatology|November 2, 2002
Terra firme-forme dermatosis of the scalpR Mallari, R D Sinclair
Gastroenterology|June 1, 1976
Serum lysozyme in inflammatory bowel diseaseF W Nugent, R Mallari, H George, et al.
Journal of the Medical Association of Georgia|May 1, 1980
Clinical note: brucellosisG A Sendelbach, K Alonson, R Mallari, et al.
The Journal of Trauma and Acute Care Surgery|June 19, 2023
Rapid clearing CT-001 restored hemostasis in mice with coagulopathy induced by activated protein CDerek S Sim, Cornell R Mallari, Maxine Bauzon, et al.
Thrombosis Research|May 31, 2022
CT-001 is a rapid clearing factor VIIa with enhanced clearance and hemostatic activity for the treatment of acute bleeding in non-hemophilia settingsDerek S Sim, Cornell R Mallari, John M Teare, et al.
Research and Practice in Thrombosis and Haemostasis|July 15, 2021
In vitro characterization of CT-001-a short-acting factor VIIa with enhanced prohemostatic activityDerek S Sim, Cornell R Mallari, John M Teare, et al.
Blood Advances|February 3, 2023
Selective modulation of activated protein C activities by a nonactive site-targeting nanobody libraryDerek S Sim, Meenal Shukla, Cornell R Mallari, et al.
Blood Advances|October 29, 2024
Divergent modulation of activated protein C pleiotropic functions by antibodies that differ by a single amino acidDerek S Sim, Meenal Shukla, Cornell R Mallari, et al.
Blood Advances|December 1, 2023
CT-001, a novel fast-clearing factor VIIa, enhanced the hemostatic activity in postpartum samplesDerek S Sim, Cornell R Mallari, Terry W Hermiston, et al.
Biomedicines|October 26, 2024
Development of a Competitive Nutrient-Based T-Cell Immunotherapy Designed to Block the Adaptive Warburg Effect in Acute Myeloid LeukemiaHuynh Cao, Jeffrey Xiao, David J Baylink, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The British Journal of Dermatology|November 2, 2002
Terra firme-forme dermatosis of the scalpR Mallari, R D Sinclair
Gastroenterology|June 1, 1976
Serum lysozyme in inflammatory bowel diseaseF W Nugent, R Mallari, H George, et al.
Journal of the Medical Association of Georgia|May 1, 1980
Clinical note: brucellosisG A Sendelbach, K Alonson, R Mallari, et al.
The Journal of Trauma and Acute Care Surgery|June 19, 2023
Rapid clearing CT-001 restored hemostasis in mice with coagulopathy induced by activated protein CDerek S Sim, Cornell R Mallari, Maxine Bauzon, et al.
Thrombosis Research|May 31, 2022
CT-001 is a rapid clearing factor VIIa with enhanced clearance and hemostatic activity for the treatment of acute bleeding in non-hemophilia settingsDerek S Sim, Cornell R Mallari, John M Teare, et al.
Research and Practice in Thrombosis and Haemostasis|July 15, 2021
In vitro characterization of CT-001-a short-acting factor VIIa with enhanced prohemostatic activityDerek S Sim, Cornell R Mallari, John M Teare, et al.
Blood Advances|February 3, 2023
Selective modulation of activated protein C activities by a nonactive site-targeting nanobody libraryDerek S Sim, Meenal Shukla, Cornell R Mallari, et al.
Blood Advances|October 29, 2024
Divergent modulation of activated protein C pleiotropic functions by antibodies that differ by a single amino acidDerek S Sim, Meenal Shukla, Cornell R Mallari, et al.
Blood Advances|December 1, 2023
CT-001, a novel fast-clearing factor VIIa, enhanced the hemostatic activity in postpartum samplesDerek S Sim, Cornell R Mallari, Terry W Hermiston, et al.
Biomedicines|October 26, 2024
Development of a Competitive Nutrient-Based T-Cell Immunotherapy Designed to Block the Adaptive Warburg Effect in Acute Myeloid LeukemiaHuynh Cao, Jeffrey Xiao, David J Baylink, et al.
Pageof 2